Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis - Top-Institutions - MDSpire

Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis

  • By

  • Ping-Huai Wang

  • Shih-Lung Cheng

  • Chin-Chung Shu

  • Hao-Chien Wang

  • February 14, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    National Jewish Health
    National Jewish Health

    Denver, CO

    Key Differentiators

    • Pulmonology
    • Respiratory Medicine
    • Radiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pulmonology
    • Radiology
    • Nutrition

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Pulmonology
    • Radiology
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Pulmonology
    • Radiology
    • Nutrition Science

Original Source(s)

Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis

  • by Ping-Huai Wang, Shih-Lung Cheng, Chin-Chung Shu, Hao-Chien Wang

  • February 14, 2026

Related Content

Not All Lung Bacteria Are the Enemy

Cross-disease meta-analysis also found modest associations with lung function, though findings varied by disease type

Pulmonary Complications After Non-Cardiothoracic Surgery in Patients with Bronchiectasis: A Retrospective Cohort Study

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.